Christopher J DeRespino
Mr. DeRespino is responsible for leading business development, corporate strategy and building additional corporate infrastructure and capabilities over time. Previously, Mr. DeRespino was Chief Business Officer and acting Chief Financial Officer at Adverum Biotechnologies, and spent more than seven years at Amgen, most recently as executive director of business development. Earlier in his career, he held positions of increasing responsibility in business development at Onyx Pharmaceuticals prior to its acquisition by Amgen and at Pfizer. Mr. DeRespino holds an M.B.A. from NYU Stern and a B.S.E in Biomedical Engineering from The Johns Hopkins University.